Prof. Javier Cortés (MD, PhD) is a medical oncologist and Head of the International Breast Cancer Center (IBCC) in Barcelona, Spain, and Senior Clinical Investigator of the Breast Cancer Research Programme at the Vall d’Hebron Institute of Oncology (VHIO). A globally recognised expert in breast cancer, he has served as principal investigator in landmark international clinical trials leading to the approval of pertuzumab, eribulin, and sacituzumab govitecan for metastatic breast cancer. He has authored more than 350 peer-reviewed publications and presented at over 800 international conferences. He is a member of ESMO, ASCO, and SEOM.